An investigation into Benitec Biopharma Inc. (NASDAQ:BNTC)’s technical aspects

The price of Benitec Biopharma Inc. (NASDAQ: BNTC) closed at $0.19 in the last session, up 5.56% from day before closing price of $0.18. In other words, the price has increased by $+0.0100 from its previous closing price. On the day, 429672 shares were traded.

Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report

Sponsored

Ratios:

We take a closer look at BNTC’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.70 and its Current Ratio is at 5.70. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

On April 20, 2020, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $14.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 09 when Oliveira Steven Michael bought 10,553 shares for $3.04 per share. The transaction valued at 32,126 led to the insider holds 1,000,000 shares of the business.

Oliveira Steven Michael bought 37,947 shares of BNTC for $120,687 on Nov 29. The 10% Owner now owns 989,447 shares after completing the transaction at $3.18 per share.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 73.97 while its Price-to-Book (P/B) ratio in mrq is 0.14.

Stock Price History:

Over the past 52 weeks, BNTC has reached a high of $3.34, while it has fallen to a 52-week low of $0.13. The 50-Day Moving Average of the stock is 0.2522, while the 200-Day Moving Average is calculated to be 1.1388.

Shares Statistics:

According to the various share statistics, BNTC traded on average about 585.72K shares per day over the past 3-months and 373.36k shares per day over the past 10 days. A total of 27.98M shares are outstanding, with a floating share count of 25.76M. Insiders hold about 7.93% of the company’s shares, while institutions hold 58.40% stake in the company. Shares short for BNTC as of Oct 13, 2022 were 81.53k with a Short Ratio of 0.33M, compared to 43.67k on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 0.32% and a Short% of Float of 0.33%.

Earnings Estimates

The company has 2 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.12 and low estimates of -$0.17.

Analysts are recommending an EPS of between -$0.48 and -$0.66 for the fiscal current year, implying an average EPS of -$0.57. EPS for the following year is -$0.54, with 2 analysts recommending between -$0.26 and -$0.83.